The current P/E ratio for Mimedx Group stock as of Jun 3, 2026 is 17.19. This is calculated based on the TTM EPS of $0.21 and the stock price of $3.61 per share. The PE ratio has decreased by 25% from its last 4 quarters average of 23.0.
The average historical PE ratio of Mimedx Group for the last ten years is 30.54. The current price-to-earnings ratio of 17.19 is 44% less than the historical average. Analyzing the last ten years, MDXG's PE ratio reached its highest point in the Dec 2016 quarter at 80.55, when the price was $8.86 and the EPS was $0.11. The lowest point was recorded in the Sep 2024 quarter, when it reached 9.38 with a price of $5.91 and an EPS of $0.63.
Maximum annual increase: 140.74% in 2016
Maximum annual decrease: -82.59% in 2015
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 20.52 | -38.14% | $6.77 | $0.33 |
| 2024 | 33.17 | 51.25% | $9.62 | $0.29 |
| 2023 | 21.93 | N/A | $8.77 | $0.4 |
| 2022 | N/A | N/A | $2.78 | -$0.33 |
| 2021 | N/A | N/A | $6.04 | -$0.15 |
| 2020 | N/A | N/A | $9.08 | -$0.77 |
| 2019 | N/A | N/A | $7.58 | -$0.24 |
| 2018 | N/A | N/A | $1.79 | -$0.28 |
| 2017 | 20.67 | -74.34% | $12.61 | $0.61 |
| 2016 | 80.55 | 140.74% | $8.86 | $0.11 |
| 2015 | 33.46 | -82.59% | $9.37 | $0.28 |
| 2014 | 192.17 | N/A | $11.53 | $0.06 |
| 2013 | N/A | N/A | $8.74 | -$0.04 |
| 2012 | N/A | N/A | $3.84 | -$0.09 |
| 2011 | N/A | N/A | $1.13 | -$0.14 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 18.81 | -8.33% | $3.95 | $0.21 |
| Dec 2025 | 20.52 | -17.69% | $6.77 | $0.33 |
| Sep 2025 | 24.93 | -10.23% | $6.98 | $0.28 |
| Jun 2025 | 27.77 | -1.35% | $6.11 | $0.22 |
| Mar 2025 | 28.15 | -15.13% | $7.6 | $0.27 |
| Dec 2024 | 33.17 | 253.62% | $9.62 | $0.29 |
| Sep 2024 | 9.38 | -13.39% | $5.91 | $0.63 |
| Jun 2024 | 10.83 | -26.87% | $6.93 | $0.64 |
| Mar 2024 | 14.81 | -32.47% | $7.7 | $0.52 |
| Dec 2023 | 21.93 | N/A | $8.77 | $0.4 |
| Sep 2023 | N/A | N/A | $7.29 | -$0.02 |
| Jun 2023 | N/A | N/A | $6.61 | -$0.17 |
| Mar 2023 | N/A | N/A | $3.41 | -$0.28 |
| Dec 2022 | N/A | N/A | $2.78 | -$0.33 |
| Sep 2022 | N/A | N/A | $2.87 | -$0.31 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of MDXG is under its 3, 5 and 10-year averages.
Mimedx Group's price to earnings (P/E) of 17.19 is higher than the industry average but lower than the Healthcare sector average. Looking at the Healthcare sector average of 23.02, Mimedx Group's price to earnings (P/E) is 25% lower.
When compared to its peer stocks MDT and STE, MDXG's PE ratio is lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MDXG Mimedx Group Inc | 18.02 | $563.76M |
| MDT Medtronic plc | 22.72 | $105.02B |
| STE STERIS plc | 26.63 | $20.71B |
| TFX Teleflex Inc | N/A | $5.85B |
| ATEC Alphatec Holdings Inc | N/A | $1.22B |
The price to earnings ratio for MDXG stock as of Jun 3, 2026, stands at 17.19.
The 3-year average PE ratio for MDXG stock is 21.03.
The 5-year average PE ratio for MDXG stock is 21.03.
The highest quarterly PE ratio in the last ten years has been 80.55 and it was in the Dec 2016 quarter.
The current PE ratio of MDXG is 44% lower than the 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jun 3, 2026), Mimedx Group's share price is $3.61. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.21. Therefore, Mimedx Group's price to earnings ratio for today is 17.19. PE RATIO(17.19) = STOCK PRICE($3.61) / TTM EPS($0.21)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.